ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-24 (Wednesday)12,344REGN holding increased by 5USD 9,674,116REGN holding decreased by -14097USD 9,674,1165USD -14,097 USD 783.71 USD 785.17
2025-12-23 (Tuesday)12,339USD 9,688,213REGN holding increased by 71690USD 9,688,2130USD 71,690 USD 785.17 USD 779.36
2025-12-22 (Monday)12,339REGN holding increased by 4USD 9,616,523REGN holding increased by 143736USD 9,616,5234USD 143,736 USD 779.36 USD 767.96
2025-12-19 (Friday)12,335REGN holding decreased by -50USD 9,472,787REGN holding increased by 200014USD 9,472,787-50USD 200,014 USD 767.96 USD 748.71
2025-12-18 (Thursday)12,385REGN holding increased by 1USD 9,272,773REGN holding decreased by -12626USD 9,272,7731USD -12,626 USD 748.71 USD 749.79
2025-12-17 (Wednesday)12,384REGN holding decreased by -21USD 9,285,399REGN holding increased by 26803USD 9,285,399-21USD 26,803 USD 749.79 USD 746.36
2025-12-16 (Tuesday)12,405REGN holding increased by 1USD 9,258,596REGN holding decreased by -76902USD 9,258,5961USD -76,902 USD 746.36 USD 752.62
2025-12-15 (Monday)12,404REGN holding increased by 5USD 9,335,498REGN holding increased by 144243USD 9,335,4985USD 144,243 USD 752.62 USD 741.29
2025-12-12 (Friday)12,399REGN holding decreased by -1USD 9,191,255REGN holding decreased by -69065USD 9,191,255-1USD -69,065 USD 741.29 USD 746.8
2025-12-11 (Thursday)12,400REGN holding increased by 5USD 9,260,320REGN holding increased by 258947USD 9,260,3205USD 258,947 USD 746.8 USD 726.21
2025-12-10 (Wednesday)12,395USD 9,001,373REGN holding increased by 416844USD 9,001,3730USD 416,844 USD 726.21 USD 692.58
2025-12-09 (Tuesday)12,395REGN holding decreased by -6USD 8,584,529REGN holding decreased by -136598USD 8,584,529-6USD -136,598 USD 692.58 USD 703.26
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BHZPJ890

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-24BUY5792.770783.610 784.526USD 3,923 669.55
2025-12-24BUY5792.770783.610 784.526USD 3,923 669.55
2025-12-22BUY4783.600765.090 766.941USD 3,068 668.60
2025-12-19SELL-50773.850748.180 750.747USD -37,537 668.18 Loss of -4,128 on sale
2025-12-18BUY1752.840739.230 740.591USD 741 667.84
2025-12-17SELL-21751.990743.330 744.196USD -15,628 667.49 Loss of -1,611 on sale
2025-12-16BUY1757.350734.720 736.983USD 737 667.16
2025-12-15BUY5756.660746.375 747.403USD 3,737 666.79
2025-12-12SELL-1746.050734.380 735.547USD -736 666.47 Loss of -69 on sale
2025-12-11BUY5753.565726.455 729.166USD 3,646 666.12
2025-12-09SELL-6711.000691.890 693.801USD -4,163 665.74 Loss of -168 on sale
2025-11-28SELL-1788.980779.500 780.448USD -780 663.58 Loss of -117 on sale
2025-11-26BUY12790.980777.000 778.398USD 9,341 662.48
2025-11-26BUY12790.980777.000 778.398USD 9,341 662.48
2025-11-24BUY135773.130756.640 758.289USD 102,369 661.45
2025-11-21SELL-6764.090735.740 738.575USD -4,431 661.02 Loss of -465 on sale
2025-11-19SELL-59727.810702.630 705.148USD -41,604 660.47 Loss of -2,636 on sale
2025-11-18SELL-48727.970699.220 702.095USD -33,701 660.17 Loss of -2,013 on sale
2025-11-17BUY2711.880692.290 694.249USD 1,388 659.96
2025-11-14BUY4699.270686.000 687.327USD 2,749 659.80
2025-11-13BUY41713.580679.930 683.295USD 28,015 659.63
2025-11-12SELL-23690.780672.670 674.481USD -15,513 659.53 Loss of -344 on sale
2025-11-10SELL-18665.990653.190 654.470USD -11,780 659.48 Profit of 90 on sale
2025-11-06BUY1657.000641.260 642.834USD 643 659.55
2025-11-05BUY8646.895628.000 629.890USD 5,039 659.63
2025-11-03BUY12657.460627.500 630.496USD 7,566 659.71
2025-10-31BUY4659.760645.000 646.476USD 2,586 659.75
2025-10-30BUY31664.000645.000 646.900USD 20,054 659.78
2025-10-29BUY8652.910659.980 659.273USD 5,274 659.81
2025-10-24BUY138577.950582.700 582.225USD 80,347 660.22
2025-10-22BUY206584.740588.710 588.313USD 121,192 660.60
2025-10-20BUY5576.770582.650 582.062USD 2,910 661.44
2025-10-17BUY44578.050579.040 578.941USD 25,473 661.86
2025-10-14SELL-6572.600576.180 575.822USD -3,455 663.25 Profit of 525 on sale
2025-10-13BUY1557.730563.770 563.166USD 563 663.80
2025-10-06BUY19585.480603.650 601.833USD 11,435 664.21
2025-10-03BUY4600.000618.010 616.209USD 2,465 664.55
2025-10-02BUY4600.000605.410 604.869USD 2,419 664.89
2025-10-01BUY36599.940615.390 613.845USD 22,098 665.23
2025-09-29BUY2560.750564.910 564.494USD 1,129 666.35
2025-09-26SELL-102563.900564.610 564.539USD -57,583 666.90 Profit of 10,441 on sale
2025-09-25BUY55555.510579.000 576.651USD 31,716 667.51
2025-09-18BUY28598.710600.000 599.871USD 16,796 667.88
2025-09-17BUY43585.500587.670 587.453USD 25,260 668.34
2025-09-15BUY22572.590573.690 573.580USD 12,619 669.39
2025-09-12BUY17560.000570.000 569.000USD 9,673 670.00
2025-09-11SELL-54568.200570.760 570.504USD -30,807 670.57 Profit of 5,404 on sale
2025-09-10BUY10555.830560.000 559.583USD 5,596 671.22
2025-09-09BUY13556.530563.570 562.866USD 7,317 671.87
2025-08-27BUY8586.960597.020 596.014USD 4,768 672.89
2025-08-21BUY2598.160605.180 604.478USD 1,209 673.81
2025-08-19BUY6571.780581.690 580.699USD 3,484 674.89
2025-07-21BUY2545.530552.980 552.235USD 1,104 675.66
2025-07-18BUY57542.520550.890 550.053USD 31,353 676.45
2025-07-17BUY12550.000554.480 554.032USD 6,648 677.21
2025-07-16BUY129547.930558.350 557.308USD 71,893 677.99
2025-07-15BUY110547.960574.750 572.071USD 62,928 678.78
2025-07-03SELL-8547.360555.000 554.236USD -4,434 680.39 Profit of 1,009 on sale
2025-07-02SELL-60547.740551.500 551.124USD -33,067 681.21 Profit of 7,805 on sale
2025-06-30SELL-6525.000526.080 525.972USD -3,156 682.18 Profit of 937 on sale
2025-06-27BUY8521.000531.210 530.189USD 4,242 683.19
2025-06-26BUY4521.000524.520 524.168USD 2,097 684.21
2025-06-25BUY8520.290525.630 525.096USD 4,201 685.24
2025-06-24SELL-6522.270527.450 526.932USD -3,162 686.28 Profit of 956 on sale
2025-06-17SELL-9508.860523.010 521.595USD -4,694 692.03 Profit of 1,534 on sale
2025-06-13SELL-2529.240529.550 529.519USD -1,059 694.24 Profit of 329 on sale
2025-06-12BUY3521.840525.220 524.882USD 1,575 695.40
2025-06-06SELL-14493.220499.880 499.214USD -6,989 700.43 Profit of 2,817 on sale
2025-06-05SELL-22483.070491.770 490.900USD -10,800 701.94 Profit of 4,643 on sale
2025-06-04SELL-29484.930499.900 498.403USD -14,454 703.45 Profit of 5,946 on sale
2025-06-03BUY6487.860501.110 499.785USD 2,999 704.97
2025-06-02SELL-2490.810502.560 501.385USD -1,003 706.49 Profit of 410 on sale
2025-05-30BUY11490.280519.780 516.830USD 5,685 708.03
2025-05-29SELL-6605.390605.730 605.696USD -3,634 708.77 Profit of 618 on sale
2025-05-28SELL-4591.850606.000 604.585USD -2,418 709.62 Profit of 420 on sale
2025-05-23SELL-18588.340591.640 591.310USD -10,644 712.20 Profit of 2,176 on sale
2025-05-22BUY1596.850605.500 604.635USD 605 713.07
2025-05-21SELL-5604.620617.520 616.230USD -3,081 713.88 Profit of 488 on sale
2025-05-20BUY22614.790615.450 615.384USD 13,538 714.63
2025-05-16SELL-9594.320595.190 595.103USD -5,356 716.47 Profit of 1,092 on sale
2025-05-15BUY1584.990585.260 585.233USD 585 717.48
2025-05-14BUY18571.360580.560 579.640USD 10,434 718.63
2025-05-13BUY67574.160575.050 574.961USD 38,522 719.76
2025-05-12BUY53575.630577.990 577.754USD 30,621 720.91
2025-05-09BUY17527.780552.840 550.334USD 9,356 722.45
2025-05-08SELL-32547.670552.570 552.080USD -17,667 723.86 Profit of 5,497 on sale
2025-05-07BUY47560.930568.130 567.410USD 26,668 725.19
2025-05-06BUY11558.520606.870 602.035USD 6,622 726.55
2025-05-02BUY3605.610615.610 614.610USD 1,844 728.59
2025-05-01SELL-1590.000593.930 593.537USD -594 729.75 Profit of 136 on sale
2025-04-29BUY1568.910579.980 578.873USD 579 732.24
2025-04-28SELL-251610.860614.830 614.433USD -154,223 733.29 Profit of 29,833 on sale
2025-04-25SELL-2602.640602.790 602.775USD -1,206 734.43 Profit of 263 on sale
2025-04-24SELL-31599.760601.280 601.128USD -18,635 735.61 Profit of 4,169 on sale
2025-04-23SELL-11587.850603.770 602.178USD -6,624 736.92 Profit of 1,482 on sale
2025-04-22SELL-14585.490587.100 586.939USD -8,217 738.27 Profit of 2,119 on sale
2025-04-16SELL-39549.280561.830 560.575USD -21,862 744.90 Profit of 7,189 on sale
2025-04-11BUY40554.180555.530 555.395USD 22,216 750.15
2025-04-10BUY12546.390571.990 569.430USD 6,833 752.11
2025-04-09BUY15576.720580.730 580.329USD 8,705 753.81
2025-04-08SELL-17556.810586.030 583.108USD -9,913 755.74 Profit of 2,935 on sale
2025-04-07BUY33572.780591.540 589.664USD 19,459 757.56
2025-04-04BUY27573.450612.990 609.036USD 16,444 759.40
2025-04-02BUY25625.600628.000 627.760USD 15,694 760.75
2025-04-01BUY16617.000641.240 638.816USD 10,221 762.21
2025-03-31SELL-86634.230640.720 640.071USD -55,046 763.53 Profit of 10,618 on sale
2025-03-28SELL-8637.360642.970 642.409USD -5,139 764.85 Profit of 980 on sale
2025-03-26BUY2640.140644.000 643.614USD 1,287 767.55
2025-03-25BUY6634.140662.570 659.727USD 3,958 768.98
2025-03-24BUY12661.000667.460 666.814USD 8,002 770.16
2025-03-21BUY308658.480661.000 660.748USD 203,510 771.38
2025-03-20BUY4662.620674.830 673.609USD 2,694 772.59
2025-03-19SELL-29672.360674.570 674.349USD -19,556 773.72 Profit of 2,882 on sale
2025-03-17SELL-4678.420679.830 679.689USD -2,719 776.06 Profit of 385 on sale
2025-03-14SELL-8666.870686.980 684.969USD -5,480 777.33 Profit of 739 on sale
2025-03-13SELL-1680.610698.950 697.116USD -697 778.47 Profit of 81 on sale
2025-03-12SELL-7689.500712.460 710.164USD -4,971 779.53 Profit of 486 on sale
2025-03-11BUY2718.160747.700 744.746USD 1,489 780.27
2025-03-06BUY62698.440701.000 700.744USD 43,446 782.64
2025-03-05SELL-8687.150692.790 692.226USD -5,538 783.85 Profit of 733 on sale
2025-03-03BUY6684.870704.640 702.663USD 4,216 786.55
2025-02-28SELL-6,542698.740708.580 707.596USD -4,629,093 787.70 Profit of 524,051 on sale
2025-02-27SELL-40702.780721.000 719.178USD -28,767 788.83 Profit of 2,786 on sale
2025-02-26SELL-506706.940721.410 719.963USD -364,301 789.94 Profit of 35,409 on sale
2025-02-25SELL-34723.470739.000 737.447USD -25,073 790.85 Profit of 1,816 on sale
2025-02-24BUY50713.250725.000 723.825USD 36,191 791.93
2025-02-21BUY26700.330704.080 703.705USD 18,296 793.22
2025-02-20BUY6696.020703.140 702.428USD 4,215 794.61
2025-02-19BUY4685.660688.670 688.369USD 2,753 796.19
2025-02-18SELL-22680.000689.950 688.955USD -15,157 797.90 Profit of 2,397 on sale
2025-02-14BUY6673.600684.000 682.960USD 4,098 801.66
2025-02-13SELL-4674.270677.690 677.348USD -2,709 803.62 Profit of 505 on sale
2025-02-12SELL-76663.860670.980 670.268USD -50,940 805.81 Profit of 10,301 on sale
2025-02-06BUY10722.070734.270 733.050USD 7,331 813.06
2025-02-05SELL-30716.720729.250 727.997USD -21,840 814.69 Profit of 2,601 on sale
2025-02-03BUY4666.850673.650 672.970USD 2,692 819.35
2025-01-30SELL-42683.080689.620 688.966USD -28,937 824.49 Profit of 5,692 on sale
2025-01-28SELL-26686.330690.300 689.903USD -17,937 829.69 Profit of 3,634 on sale
2025-01-27BUY12684.710698.450 697.076USD 8,365 832.47
2025-01-24BUY22675.790693.840 692.035USD 15,225 835.55
2025-01-23BUY22694.640696.190 696.035USD 15,313 838.36
2024-12-09BUY4788.000800.990 799.691USD 3,199 840.66
2024-12-06BUY62778.000778.120 778.108USD 48,243 841.99
2024-12-04BUY46754.260756.130 755.943USD 34,773 845.59
2024-12-03BUY26749.570770.000 767.957USD 19,967 847.77
2024-12-02BUY60762.340763.890 763.735USD 45,824 849.76
2024-11-29BUY6750.220754.510 754.081USD 4,524 852.13
2024-11-27BUY2754.870762.160 761.431USD 1,523 856.99
2024-11-26SELL-68753.030754.180 754.065USD -51,276 862.46 Profit of 7,371 on sale
2024-11-26SELL-68753.030754.180 754.065USD -51,276 862.46 Profit of 7,371 on sale
2024-11-25SELL-9,616749.510757.860 757.025USD -7,279,552 865.52 Profit of 1,043,259 on sale
2024-11-22SELL-7738.000751.400 750.060USD -5,250 869.06 Profit of 833 on sale
2024-11-21BUY168744.500757.560 756.254USD 127,051 872.62
2024-11-19SELL-36744.600758.600 757.200USD -27,259 880.41 Profit of 4,436 on sale
2024-11-18BUY79762.000762.700 762.630USD 60,248 884.12
2024-11-12BUY4821.000831.000 830.000USD 3,320 886.15
2024-11-08BUY12828.420830.730 830.499USD 9,966 892.43
2024-11-08BUY12828.420830.730 830.499USD 9,966 892.43
2024-11-07BUY308824.480832.530 831.725USD 256,171 897.66
2024-11-07BUY308824.480832.530 831.725USD 256,171 897.66
2024-11-06BUY8816.650844.510 841.724USD 6,734 904.41
2024-11-06BUY8816.650844.510 841.724USD 6,734 904.41
2024-11-05SELL-20829.430836.630 835.910USD -16,718 911.23 Profit of 1,506 on sale
2024-11-05SELL-20829.430836.630 835.910USD -16,718 911.23 Profit of 1,506 on sale
2024-11-04SELL-144828.840852.010 849.693USD -122,356 919.47 Profit of 10,048 on sale
2024-11-04SELL-144828.840852.010 849.693USD -122,356 919.47 Profit of 10,048 on sale
2024-11-01SELL-40843.600862.000 860.160USD -34,406 927.90 Profit of 2,710 on sale
2024-11-01SELL-40843.600862.000 860.160USD -34,406 927.90 Profit of 2,710 on sale
2024-10-31BUY23838.200883.150 878.655USD 20,209 939.11
2024-10-31BUY23838.200883.150 878.655USD 20,209 939.11
2024-10-30SELL-152922.790935.860 934.553USD -142,052 941.44 Profit of 1,047 on sale
2024-10-30SELL-152922.790935.860 934.553USD -142,052 941.44 Profit of 1,047 on sale
2024-10-29SELL-144927.330932.380 931.875USD -134,190 943.79 Profit of 1,716 on sale
2024-10-29SELL-144927.330932.380 931.875USD -134,190 943.79 Profit of 1,716 on sale
2024-10-28BUY12928.610943.270 941.804USD 11,302 946.83
2024-10-28BUY12928.610943.270 941.804USD 11,302 946.83
2024-10-25BUY256933.020943.830 942.749USD 241,344 950.28
2024-10-25BUY256933.020943.830 942.749USD 241,344 950.28
2024-10-24BUY32928.900952.020 949.708USD 30,391 957.41
2024-10-24BUY32928.900952.020 949.708USD 30,391 957.41
2024-10-23SELL-6941.390959.600 957.779USD -5,747 965.42 Profit of 46 on sale
2024-10-23SELL-6941.390959.600 957.779USD -5,747 965.42 Profit of 46 on sale
2024-10-22BUY28962.340972.750 971.709USD 27,208 968.50
2024-10-22BUY28962.340972.750 971.709USD 27,208 968.50
2024-10-21SELL-280968.500991.240 988.966USD -276,910 0.00 Loss of -276,910 on sale
2024-10-21SELL-280968.500991.240 988.966USD -276,910 0.00 Loss of -276,910 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy